A French SME in the ranks of ovosexing technology

The ovosexing solution developed by NT2I is non-invasive and does not use the techniques usually deployed, such as hyperspectral imaging, spectrometry or MRI. To keep its secret, the SME has not filed a patent.

The project was developed in partnership with a breeder. © NT2I

Usually, this French company operates in the military sector (General Directorate of Armaments, Nexter), industrial (Michelin Group, Saint Gobin, Obut, Thales, etc.), pharmaceuticals (Bio Mérieux, Sanofi) or agri-food (Pasquier) for develop solutions that replace the human eye.

It is his know-how, using specific acquisition techniques associated with original image pre-processing algorithms and coupled with new generation on-board artificial intelligence networks, which enabled him to develop the Rose ovosexing process. in less than a year.

Rate, precocity and sensitivity

The classification algorithms identify 3 classes at the output of the equipment (female, male, infertile). According to its director Mohamed Bouabdellah “The current solution makes it possible to work at minimum rates of 20,000 eggs per hour, with ovosexing precision at 13-14 days compatible with market expectations. »

The validation tests were carried out with a breeder on brown hen strains. And this is only the beginning, says the director again. “Serious leads exist to reach below 13 days of incubation, and to develop a solution for white hens that we have not investigated for the moment. »

NT2I adopts a low cost approach, unlike other ovosexing players who sell a sexed egg service, by supplying hatcheries with turnkey equipment. This new business model would greatly reduce the costs associated with ovosexing.

Leave a Comment